# Flucelvax (TIVc or QIVc) Pregnancy Registry

> **NCT03438487** · — · COMPLETED · sponsor: **Seqirus** · enrollment: 692 (actual)

## Conditions studied

- Influenza, Human
- Pregnancy
- Birth Defect

## Interventions

- **BIOLOGICAL:** Flucelvax Trivalent Influenza Vaccine
- **BIOLOGICAL:** Flucelvax Quadrivalent Influenza Vaccine

## Key facts

- **NCT ID:** NCT03438487
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 692 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03438487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03438487, "Flucelvax (TIVc or QIVc) Pregnancy Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03438487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*